https://www.home.saxo/pl-pl/markets/stocks/nrix-xnas
Nurix Therapeutics Inc akcja | Saxo Bank
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein...
saxo banknurixtherapeuticsincakcja
https://www.kappasignal.com/2025/06/nurix-therapeutics-stock-forecast-shows.html
Nurix Therapeutics: Stock Forecast Shows Potential for Growth (NRIX)
KappaSignal is a leading financial technology firm specializing in AI-driven stock analysis and forecasting.
stock forecastnurixtherapeuticsshowspotential
https://www.chemdiv.com/company/media/pharma-news/2020/after-kymeras-raise-nurix-nabs-120m-as-it-too-hones-in-on-clinical-work/
After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work -...
After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work
kymeraraisenurixnabsclinical
https://www.nurixtx.com/
Nurix | Medicines to Outmatch Disease
Jan 11, 2025 - Discover Nurix Therapeutic's targeted protein degradation platform, combining degraders and DACs to transform cancer and autoimmune disease treatment.
nurixmedicinesdisease
https://biohired.com/jobs/107101
Senior Director, Quality Assurance at Nurix Therapeutics in Brisbane, CA | Biohired
Apply for Senior Director, Quality Assurance at Nurix Therapeutics in Brisbane, CA. Quality role. Biotech developing targeted protein degradation therapies for...
senior directorquality assurancenurixtherapeuticsbrisbane
https://www.cmlviz.com/stocks/NRIX/analysts
NRIX Wall Street Analyst Earnings Expectations, Nurix Therapeutics Inc Analysts Expectations-...
NRIX Stock Price | Nurix Therapeutics Inc(XNAS:NRIX) - one year predictions, two years predictions, earnings per share, stock estimates
wall streetnrixanalystearningsexpectations
https://stockhouse.com/companies/bullboard?symbol=nrix
NDAQ:NRIX | Stock Discussion | Nurix Therapeutics Inc
Get stock insights, analysis and discussion about Nurix Therapeutics Inc (NDAQ:NRIX). Join the NRIX discussion on Canada's largest online investor community
ndaqnrixstockdiscussionnurix
https://biotech-365.com/nurix-therapeutics-presents-new-data-demonstrating-durable-deepening-responses-in-phase-1-trial-of-bexobrutideg-nx-5948-in-patients-with-relapsed-or-refractory-chronic-lymphocytic-leukemia-cll-at/
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of...
new datanurixtherapeuticspresentsdemonstrating